However, activation of IL-1R1 on CD11c+ myeloid cells promotes the expression of the anti-inflammatory factor IL-1R antagonist (IL-1Ra), limiting IL-1β-induced tubular cell injury in vitro and ameliorating AKI [60]. The gene discussed is IL1B; the disease is acute kidney injury.